1. Ellis MS, Kasper ZA, Cicero TJ. Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018 Dec 1;193:14–20.
2. Giang L, Thuy D, Trang N, Okafor C, Li M, Shoptaw S. Severity of methamphetamine use among methadone patients in Vietnam: Prevalence and correlates. In San Antonio, Texas; 2019.
3. Michel L, Des Jarlais DC, Duong Thi H, Khuat Thi Hai O, Pham Minh K, Peries M, et al. Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. Drug Alcohol Depend. 2017 Oct;179:198–204.
4. UNODC GS programme. Synthetic Drugs in East and Southeast Asia - Latest developments and challenges. 2020 May p. 116.
5. Bao Y-P, Liu Z-M, Li J-H, Zhang R-M, Hao W, Zhao M, et al. Club drug use and associated high-risk sexual behaviour in six provinces in China. Addict Abingdon Engl. 2015 Jan;110 Suppl 1:11–9.
6. Carrico AW, Nil E, Sophal C, Stein E, Sokunny M, Yuthea N, et al. Behavioral interventions for Cambodian female entertainment and sex workers who use amphetamine-type stimulants. J Behav Med. 2016;39(3):502–10.
7. Colfax G, Santos G-M, Chu P, Vittinghoff E, Pluddemann A, Kumar S, et al. Amphetamine-group substances and HIV. Lancet Lond Engl. 2010 Aug 7;376(9739):458–74.
8. Zhang C, Liu Y, Sun X, Wang J, Lu H-Y, He X, et al. Substance use and HIV-risk behaviors among HIV-positive men who have sex with men in China: repeated measures in a cohort study design. AIDS Care. 2017;29(5):644–53.
9. Liu D, Gu J, Xu H, Hao C, Jiao M, Zhang X, et al. Club drugs and alcohol abuse predicted dropout and poor adherence among methadone maintenance treatment patients in Guangzhou, China. AIDS Care. 2017;29(4):458–63.
10. Wang R, Ding Y, Bai H, Duan S, Ye R, Yang Y, et al. Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China. PLOS ONE. 2015 Jul 21;10(7):e0133431.
11. Carrico AW, Cherenack EM, Roach ME, Riley ED, Oni O, Dilworth SE, et al. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS Lond Engl. 2018 27;32(6):767–71.
12. Carrico AW, Hunt PW, Neilands TB, Dilworth SE, Martin JN, Deeks SG, et al. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy. JAIDS J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):89–93.
13. Carrico AW, Flentje A, Kober K, Lee S, Hunt P, Riley ED, et al. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun. 2018;71:108–15.
14. Horvath KJ, Carrico AW, Simoni J, Boyer EW, Amico KR, Petroll AE. Engagement in HIV Medical Care and Technology Use among Stimulant-Using and Nonstimulant-Using Men who have Sex with Men. AIDS Res Treat [Internet]. 2013 [cited 2021 Jan 25];2013. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705882/
15. Korthuis, P. Todd, Bart, Gavin, Kunkel L, Diep NB, Brinkerhoff C, Giang LM. Buprenorphine versus Methadone impact on the HIV care continuum in Vietnam: BRAVO study 6-month outcomes. In San Diego; 2018.
16. Alam-mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country. Asian J Psychiatry. 2015 Aug;16:17–25.
17. Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013 Nov;24(6):e115-116.
18. Watt MH, Meade CS, Kimani S, MacFarlane JC, Choi KW, Skinner D, et al. The impact of methamphetamine (“tik”) on a peri-urban community in Cape Town, South Africa. Int J Drug Policy. 2014 Mar;25(2):219–25.
19. Baingana F, al’Absi M, Becker AE, Pringle B. Global research challenges and opportunities for mental health and substance-use disorders. Nature. 2015 Nov 19;527(7578):S172-177.
20. Petersen I, Evans-Lacko S, Semrau M, Barry MM, Chisholm D, Gronholm P, et al. Promotion, prevention and protection: interventions at the population- and community-levels for mental, neurological and substance use disorders in low- and middle-income countries. Int J Ment Health Syst. 2016;10:30.
21. AshaRani P, Hombali A, Seow E, Ong WJ, Tan JH, Subramaniam M. Non-pharmacological interventions for methamphetamine use disorder: a systematic review. Drug Alcohol Depend. 2020 Jul 1;212:108060.
22. Knight R, Karamouzian M, Carson A, Edward J, Carrieri P, Shoveller J, et al. Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review. Drug Alcohol Depend. 2019 Jan;194:410–29.
23. Radfar SR, Rawson RA. Current Research on Methamphetamine: Epidemiology, Medical and Psychiatric Effects, Treatment, and Harm Reduction Efforts. Addict Health. 2014;6(3–4):146–54.
24. Polcin DL, Bond J, Korcha R, Nayak MB, Galloway GP, Evans K. Randomized Trial of Intensive Motivational Interviewing for Methamphetamine Dependence. J Addict Dis. 2014 Jul 3;33(3):253–65.
25. Galloway GP, Polcin D, Kielstein A, Brown M, Mendelson J. A Nine Session Manual of Motivational Enhancement Therapy for Methamphetamine Dependence: Adherence and Efficacy. J Psychoactive Drugs. 2007 Nov 1;39(sup4):393–400.
26. Benishek LA, Dugosh KL, Kirby KC, Matejkowski J, Clements NT, Seymour BL, et al. Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addict Abingdon Engl. 2014 Sep;109(9):1426–36.
27. Brown HD, DeFulio A. Contingency management for the treatment of methamphetamine use disorder: A systematic review. Drug Alcohol Depend. 2020 Nov;216:108307.
28. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008 Feb;165(2):179–87.
29. Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000 Feb 1;58(1–2):55–66.
30. Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis [Internet]. Centre for Reviews and Dissemination (UK); 2006 [cited 2020 Feb 25]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK72392/
31. Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addict Abingdon Engl. 2006 Feb;101(2):192–203.
32. Ginley MK, Pfund RA, Rash CJ, Zajac K. Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: A meta-analysis. J Consult Clin Psychol. 2021 Jan;89(1):58–71.
33. Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addict Abingdon Engl. 2004 Jun;99(6):708–17.
34. Reback CJ, Fletcher JB, Shoptaw S, Mansergh G. Exposure to Theory-Driven Text Messages is Associated with HIV Risk Reduction Among Methamphetamine-Using Men Who have Sex with Men. AIDS Behav. 2015 Jun;19 Suppl 2:130–41.
35. Reback CJ, Fletcher JB, Swendeman DA, Metzner M. Theory-based Text-Messaging to Reduce Methamphetamine Use and HIV Sexual Risk Behaviors among Men who have Sex with Men: Automated Unidirectional Delivery Outperforms Bidirectional Peer Interactive Delivery. AIDS Behav. 2019 Jan;23(1):37–47.
36. Reback CJ, Fletcher JB, Kisler KA. Text Messaging Improves HIV Care Continuum Outcomes Among Young Adult Trans Women Living with HIV: Text Me, Girl! AIDS Behav. 2021 Sep;25(9):3011–23.
37. Reback CJ, Fletcher JB, Leibowitz AA. Cost effectiveness of text messages to reduce methamphetamine use and HIV sexual risk behaviors among men who have sex with men. J Subst Abuse Treat. 2019 May;100:59–63.
38. Gómez W, Olem D, Andrews R, Discepola MV, Ambrose P, Dilworth SE, et al. Optimizing Contingency Management With Methamphetamine-Using Men Who Have Sex With Men. Cogn Behav Pract. 2018 May 1;25(2):286–95.
39. Parsons JT, John SA, Millar BM, Starks TJ. Testing the Efficacy of Combined Motivational Interviewing and Cognitive Behavioral Skills Training to Reduce Methamphetamine Use and Improve HIV Medication Adherence Among HIV-Positive Gay and Bisexual Men. AIDS Behav. 2018 Aug;22(8):2674–86.
40. Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction. J Addict Med. 2016 Mar;10(2):91–101.
41. Assanangkornchai S, Balthip Q, Edwards JG, assistance of the ASSIST-SBI Development Co-investigators. Implementing the Alcohol, Smoking, Substance Involvement Screening Test and linked brief intervention service in primary care in Thailand. J Public Health Oxf Engl. 2014 Sep;36(3):443–9.
42. Sorsdahl K, Myers B, Ward C, Matzopoulos R, Mtukushe B, Nicol A, et al. Screening and brief interventions for substance use in emergency departments in the Western Cape province of South Africa: views of health care professionals. Int J Inj Contr Saf Promot. 2014;21(3):236–43.
43. Wechsberg WM, Luseno WK, Karg RS, Young S, Rodman N, Myers B, et al. Alcohol, cannabis, and methamphetamine use and other risk behaviors among Black and Coloured South African women: a small randomized trial in the Western Cape. Int J Drug Policy. 2008 Apr;19(2):130–9.
44. Chen W, Hong Y, Zou X, McLaughlin MM, Xia Y, Ling L. Effectiveness of prize-based contingency management in a methadone maintenance program in China. Drug Alcohol Depend. 2013 Nov 1;133(1):270–4.
45. Hser Y-I, Li J, Jiang H, Zhang R, Du J, Zhang C, et al. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addict Abingdon Engl. 2011 Oct;106(10):1801–9.
46. Cohen A, McGregor C. The Emergence of Methamphetamine in Thailand: Interventions and Treatment. In Richard Pates, Diane Riley. In: Interventions for Amphetamine Misuse. Oxford: Wiley-Blackwell Publishing. 2010. p. 159–71.
47. Magidson JF, Gouse H, Burnhams W, Wu CYY, Myers B, Joska JA, et al. Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting. Addict Behav. 2017;66:132–7.
48. Nguyen Huu C, Kieu Cong Thuy. Application of Matrix model in support of trreatment and recovery for ATS dependents (Nghiên cứu sử dụng liệu pháp tâm lý Matrix trong hỗ trợ điều trị nghiện và phục hồi chức năng cho người nghiện ma túy tổng hợp dạng amphetamine). In Hanoi, Vietnam; 2016.
49. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation Hybrid Designs. Med Care. 2012 Mar;50(3):217–26.
50. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4(1):50.
51. Damschroder LJ, Hagedorn HJ. A guiding framework and approach for implementation research in substance use disorders treatment. Psychol Addict Behav. 2011;25(2):194–205.
52. Hanoi Centre for Disease Control. MMT program data. 2021.
53. HCMC Centre for Disease Control. MMT program data. 2021.
54. Roll JM, Shoptaw S. Contingency management: Schedule effects. Psychiatry Res. 2006 Sep 30;144(1):91–3.
55. UNAIDS. Costing Guidelines for HIV Prevention Strategies. 2000.
56. Hintz J. PASS 12 [Internet]. 2013 [cited 2021 Apr 23]. Available from: https://www.ncss.com/
57. Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy SA. A “SMART” design for building individualized treatment sequences. Annu Rev Clin Psychol. 2012;8:21–48.
58. Almirall D, Nahum-Shani I, Sherwood NE, Murphy SA. Introduction to SMART designs for the development of adaptive interventions: with application to weight loss research. Transl Behav Med. 2014 Sep;4(3):260–74.
59. Nahum-Shani I, Qian M, Almirall D, Pelham WE, Gnagy B, Fabiano GA, et al. Experimental design and primary data analysis methods for comparing adaptive interventions. Psychol Methods. 2012 Dec;17(4):457–77.
60. Neumann PJ, Sanders GD, Russell LB, Ganiats TG, Siegel JE. Cost-effectiveness in Health and Medicine. Oxford University Press; 2017. 537 p.